Cogent Biosciences Inc (COGT)

Cost of Revenue

$2.33M

TTM · Period ending: · USD

COGT logo

COGT Cost of Revenue

Latest reported$2.33M
COGT TTM Cost of Revenue ($0.00 → $2.33M)
High-resolution chart · PNG

COGT cost of revenue history

Trailing twelve months (TTM) · USD. Each value covers four complete reported quarters.

Cogent Biosciences Inc Cost of Revenue — Trailing twelve months (TTM) (USD)
Period endingCost of Revenue (USD)
2,332,000
3,489,000
2,334,000
1,157,000
1,157,000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
5,003,000
10,132,000
19,630,000
29,984,000
35,316,000
40,804,000
42,816,000
32,462,000
22,127,000
11,510,000
0
0
0
0
0
39,658,000
40,424,000
Data is provided for informational purposes only and does not constitute investment advice. Past performance is not indicative of future results.